Bernie Sanders targets pharma CEOs; and Pfizer insider trading

U.S. Senate health committee chair Bernie Sanders subpoenaed or this, this, this, and this. Only Bristol Myers Squibb, CEO Chris Boerner, agreed to testify at a Jan. 25 hearing. Sanders invited the Johnson & Johnson and Merck executives, but they refused. Sanders is accused of retaliating against companies that sued the Biden administration to stop a program to negotiate how much Medicare pays for high-cost drugs. The committee’s vote on whether to use subpoenas to force J & J and Merck CEOs to testify on U.S. drug prices is expected on Jan. 31. Bloomberg Law reports.

Source link

error: Content is protected !!